The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
Vanguard Russell 2000 ETF: A Smart Buy for Small-Cap Exposure The Russell 2000 certainly represents the most comprehensive way to invest in small caps, but it's important to know exactly what you're buying.
3 Consumer Stocks to Buy at a Discount These consumer stocks remain too cheap to pass up, even after recently surging in price.
3 Predictions for Alphabet in 2026 Alphabet's heavy AI push can change the trajectory of its core business.
2 Top Dividend Stocks to Buy in February These two dividend stocks should reward investors.
Battle Royale: Oklo vs. NuScale Power. Only 1 Can Make You Rich. Oklo and NuScale could disrupt the nuclear energy industry. Which one will emerge as a long-term winner?
Is Nebius the Next Amazon? Nebius is growing its own computing platform.
2 No-Brainer High-Yield Energy Stocks to Buy for Reliable Income Right Now If you're on the hunt for high-yielding dividend stocks, look no further than these two pipeline operators.
Alphabet's Fastest-Growing Segment Makes the "Magnificent Seven" Stock an AI Leader This division is contributing a much larger share of the company's sales and profits these days.
Here's How Fiserv Stock Beats the Market From Here The financial giant's stock has tumbled 73% over the past year.
Is Lumen Technologies Stock Your Ticket to Becoming a Millionaire? The telecommunications giant's strategic shift capitalizes on growing AI opportunities.
Life360 Board Director Sells Nearly 8k Shares as Company Expands Partnership with Uber This location-based tech firm recently expanded its partnership with the world's largest ride-sharing app.
Alaska Air Group CCO Sells 5500 Shares After Company Invests $3B into Hub Airports An executive at Alaska Air Group recently sold 5,500 shares, following the company's strong start to 2026, marked by heavy investments to expand its operations.
Why Feb. 26 Could Be a Huge Day for the Stock Market Investors will listen closely to one key message -- and it may impact their investment decisions.
Should You Buy QuantumScape While It's Below $9? The next-generation battery developer is making important progress in its business, but is it a buy today?
How Many Markets Does Apple Dominate? The Answer Might Shock You The iPhone recently took the crown to become the world's top-selling smartphone. That's just the tip of the iceberg.
Vanguard Says: International Stocks Could Beat the U.S. for Years Vanguard research expects 10 years of better stock investment opportunities outside of America.
Where Will AST SpaceMobile Stock Be in 5 Years? The satellite internet stock has taken investors for a wild ride.
Costco Stock Is Soaring, but Is It Getting Ahead of Itself? Is the company delivering enough growth to support its high valuation?
Investment Firm Purchases Sonos Shares, As Company Prepares for New Product Line After significant revenue losses, Sonos may be on a comeback, and an investment firm appears bullish on the audio company's future.
This Fund Dumped $13 Million in Graphic Packaging Stock Amid 50% Share Slide and Slumping Profits Graphic Packaging delivers fiber-based packaging solutions to major consumer brands worldwide, serving food, beverage, and retail sectors.
What to Know About This Fund's $12 Million Bet on Dauch Stock Detroit-based Dauch Corporation supplies driveline and metal forming systems to global automotive manufacturers across multiple platforms.
Don't Even Think About Buying Tilray Stock Until You Read This Warning Tilray is moving in the right direction, but it still isn't a sustainably profitable business.
Kirby Posts $6.33 EPS in 2025 as Fund Makes $25 Million Bet on Marine Operator Kirby Corporation moves petrochemicals and refined products by barge, serving vital U.S. energy and industrial supply chains.
Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet Vistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide.
Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth Array Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide.
Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio Enviri delivers environmental and specialty waste solutions for industrial clients through long-term contracts and value-added products.
Urban Outfitters CCO Sells 18,666 Shares for $1.3 Million The Hayne family have been on a selling spree the last few months, but these transactions typically have one thing in common.
Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets.
The Best Stocks to Invest $50,000 in Right Now Investors don't have to look any further than these two dominant internet firms.
Is Cognex Stock a Buy or Sell After a Director Dumped Shares Worth $128,000? This automation technology leader, known for machine vision systems, reported a notable insider sale amid strong one-year share performance.
Prediction: 3 Stocks That'll Be Worth More Than Walmart 5 Years From Now Walmart has crushed the S&P 500 in recent years, but the red-hot stock is due for a cooldown.
Where Will Rocket Lab Stock Be in 10 Years? The spaceflight company has shot up like, well, a rocket since its market debut a few years ago.
Novartis: This Big Pharma Giant Could Be a Sleep‑at‑Night Core Holding for Decades Novartis has a solid portfolio of drugs and a pipeline that should keep the business humming.
JFrog's CTO Sold Shares Worth $2.5 Million. Is the Stock a Buy or Sell? JFrog, a leader in DevOps software solutions, reported a notable insider sale amid ongoing growth in enterprise adoption.
Is CrowdStrike Stock a Buy After Falling 17% Year to Date? CrowdStrike is still growing quickly, but the stock's valuation assumes that pace holds up with little noise.
Betting Against Wall Street: The Inverse ETF Surge No One Is Talking About The ProShares UltraShort Financials ETF ratchets up bearish bets on a popular sector.
2 Quantum Computing Stocks That Could Make a Millionaire Quantum computing is still a high-risk frontier, but for patient investors, these two tickers could be tomorrow's generational wealth creators.
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million Praxis Precision Medicines targets neurological and psychiatric disorders with a pipeline of precision therapies for CNS conditions.
Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position Celcuity develops targeted cancer therapies and diagnostic platforms, with a focus on advancing precision medicine in oncology.
2 Financial Stocks Poised for a Comeback in 2026 Both stocks are in the Berkshire Hathaway portfolio, selected by former CEO Warren Buffett.
Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction Apogee Therapeutics develops biologic therapies targeting dermatology and respiratory conditions, with lead candidates in clinical trials.
My 5 Favorite Dividend Stocks to Buy Right Now There are several solid prospects to choose from right now, but there's a reason I can't get these particular names out of my head.
$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges Arcellx develops next-generation cell therapies targeting multiple myeloma and other hematologic cancers in the biotechnology sector.
Arohi Asset Exits a Big Software Bet by Selling 1.7M DoubleVerify (DV) Shares Worth $20.6 Million DoubleVerify provides digital media measurement and analytics tools for advertisers and publishers across multiple sectors.
Could Buying XRP Today Set You Up for Life? Turning a modest upfront investment in XRP into life-changing wealth is harder than it sounds.
Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million Nurix Therapeutics develops targeted cancer and immune disorder therapies, supported by partnerships with leading pharma companies.
Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% This clinical-stage biotech develops antibody therapies for cancer and infectious diseases, leveraging proprietary discovery platforms.
Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio It's about striking that perfect balance between chasing growth and protecting what you already have.
Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year This clinical-stage biotech develops targeted cancer therapies, leveraging bispecific antibodies and strategic industry partnerships.
Vertiv Stock: Buy, Sell, or Hold? Vertiv has seen incredibly strong demand from data center operators for its cooling and power solutions.
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 Krystal Biotech develops redosable gene therapies targeting rare skin diseases, with a late-stage clinical pipeline and expanding portfolio.
Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26% Scholar Rock develops therapies for neuromuscular and oncological diseases, leveraging a proprietary platform to target unmet medical needs.
Why Cleveland's Culture Scene Makes It a Retirement Pick That Doesn't Feel "Sleepy" Cleveland may sound like a sleepy little midwestern town. However, it's anything but sleepy.
Alphabet Has a Plan for Worldwide AI Dominance Will the tech giant be able to follow through on its aspirations?
This Fund Sold its Entire Stake in SSR Mining Stock After a 200% Rally. Should You Too? SSR Mining is a global precious metals producer with operations spanning gold, silver, and base metals across four continents.
